ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120202.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $799 | -29.7% | 505,993 | -3.9% | 0.00% | -50.0% |
Q2 2023 | $1,137 | +243.5% | 526,355 | +233.9% | 0.00% | – |
Q1 2023 | $331 | -9.1% | 157,655 | -5.1% | 0.00% | – |
Q4 2022 | $364 | -99.9% | 166,076 | -11.4% | 0.00% | -100.0% |
Q3 2022 | $563,000 | +31.9% | 187,525 | +24.3% | 0.00% | 0.0% |
Q2 2022 | $427,000 | -28.0% | 150,825 | +36.1% | 0.00% | 0.0% |
Q1 2022 | $593,000 | -37.6% | 110,855 | -12.8% | 0.00% | 0.0% |
Q4 2021 | $950,000 | -41.8% | 127,155 | -29.2% | 0.00% | -50.0% |
Q3 2021 | $1,631,000 | +89.7% | 179,655 | +1.9% | 0.00% | +100.0% |
Q2 2021 | $860,000 | -20.1% | 176,255 | -27.2% | 0.00% | 0.0% |
Q1 2021 | $1,077,000 | -13.0% | 241,960 | -24.2% | 0.00% | 0.0% |
Q4 2020 | $1,238,000 | -6.1% | 319,130 | -21.9% | 0.00% | 0.0% |
Q3 2020 | $1,319,000 | -18.8% | 408,430 | +11.6% | 0.00% | 0.0% |
Q2 2020 | $1,624,000 | +177.6% | 365,830 | +75.0% | 0.00% | 0.0% |
Q1 2020 | $585,000 | -29.9% | 209,000 | +4.5% | 0.00% | 0.0% |
Q4 2019 | $834,000 | +23.0% | 199,920 | +3.3% | 0.00% | 0.0% |
Q3 2019 | $678,000 | – | 193,620 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tikvah Management LLC | 1,225,833 | $9,157,000 | 2.55% |
Stonepine Capital Management, LLC | 525,531 | $3,926,000 | 1.80% |
Telemetry Investments, L.L.C. | 176,782 | $1,321,000 | 1.70% |
TANG CAPITAL MANAGEMENT LLC | 1,113,453 | $8,317,000 | 1.67% |
VR Adviser, LLC | 1,565,000 | $11,691,000 | 1.60% |
Deep Track Capital, LP | 1,100,000 | $8,217,000 | 0.58% |
EAM Investors, LLC | 252,280 | $1,885,000 | 0.31% |
EAM Global Investors LLC | 152,792 | $1,141,000 | 0.20% |
FEDERATED HERMES, INC. | 5,222,250 | $39,010,000 | 0.07% |
Alyeska Investment Group, L.P. | 674,975 | $5,042,000 | 0.06% |